(Q57306343)

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Neuropathology of variants of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Dementia as the most common presentation of cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

J. Clifford Richardson and 50 years of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Atypical progressive supranuclear palsy with corticospinal tract degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticodentatonigral Degeneration With Neuronal Achromasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Unusual clinical presentations of cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cortical-basal ganglionic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical Features of Pathologic Subtypes of Behavioral-Variant Frontotemporal Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Language function and dysfunction in corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

The many faces of corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Symmetric corticobasal degeneration (S-CBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Risk factors for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Risk factors for progressive supranuclear palsy: a case-control study in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Familial progressive supranuclear palsy. Description of a pedigree and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical genetics of familial progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Genetic evidence for the involvement of tau in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A common inversion under selection in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A clinical rating scale for progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Progressive supranuclear palsy: a survey of the disease course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

The alien hand and related signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Alzheimer's disease presenting as corticobasal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

The evolution and pathology of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticobasal degeneration as cause of progressive non-fluent aphasia: clinical, radiological and pathological study of an autopsy case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Apraxia of speech: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

TDP-43 in differential diagnosis of motor neuron disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Constant and severe involvement of Betz cells in corticobasal degeneration is not consistent with pyramidal signs: a clinicopathological study of ten autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Study of the rostral midbrain atrophy in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

MR imaging of brainstem atrophy in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Imaging of corticobasal degeneration syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Increased CSF tau protein in corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Is the pathology of corticobasal syndrome predictable in life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ballooned neurons expressing alphaB-crystallin as a constant feature of the amygdala in argyrophilic grain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Oligodendroglial microtubular masses: an abnormality observed in some human neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Neurodegenerative disorders with extensive tau pathology: a comparative study and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Apolipoprotein E ε4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies, and Frontotemporal Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Lewy bodies in progressive supranuclear palsy represent an independent disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Argyrophilic grain disease is a sporadic 4-repeat tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Neurofibrillary pathology in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Substructure of 20 nm filaments of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ultrastructure of Neurofibrillary Tangles in Steele-Richardson-Olszewski Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Ubiquitin immunoreactivity of paired helical filaments differs in Alzheimer's disease and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Excessive dopamine neuron loss in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Knock-out and transgenic mouse models of tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Cholinergic vesicular transporters in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A decade of tau transgenic animal models and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Transgenic mouse models of tauopathy in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Alzheimer's disease and tauopathy studies in flies and worms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Transgenic Drosophila models of Alzheimer's disease and tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Recent advances in experimental modeling of the assembly of tau filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Molecular dissection of the paired helical filament

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Mechanisms of tau-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Microtubule-associated protein tau, paired helical filaments, and phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Bcl-2 and Bax protein expression in neurofibrillary tangles in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Aging and oxidative stress in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Expression and activity of antioxidants in the brain in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Evidence for oxidative stress in Pick disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Akt and CHIP coregulate tau degradation through coordinated interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15

Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781444341256.CH15